Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-132 |
Sentence |
denotes |
Early Goal-Directed Therapy With and Without Intermittent Superior Vena Cava Oxygen Saturation Monitoring in Pediatric Septic Shock: |
T2 |
133-163 |
Sentence |
denotes |
A Randomized Controlled Trial. |
T3 |
164-174 |
Sentence |
denotes |
OBJECTIVE: |
T4 |
175-337 |
Sentence |
denotes |
To compare early goal-directed therapy (EGDT) 'with' and 'without' intermittent superior vena cava oxygen saturation (ScvO2) monitoring in pediatric septic shock. |
T5 |
338-345 |
Sentence |
denotes |
DESIGN: |
T6 |
346-385 |
Sentence |
denotes |
Open label randomized controlled trial. |
T7 |
386-394 |
Sentence |
denotes |
SETTING: |
T8 |
395-451 |
Sentence |
denotes |
Pediatric intensive care unit in a tertiary care center. |
T9 |
452-465 |
Sentence |
denotes |
PARTICIPANTS: |
T10 |
466-517 |
Sentence |
denotes |
Children aged 1 month to 12 year with septic shock. |
T11 |
518-531 |
Sentence |
denotes |
INTERVENTION: |
T12 |
532-668 |
Sentence |
denotes |
Patients not responding to fluid resuscitation (up to 40 mL/kg) were randomized to EGDT 'with' (n=59) and 'without' (n=61) ScvO2 groups. |
T13 |
669-839 |
Sentence |
denotes |
Resuscitation was guided by ScvO2 monitoring at 1-hour, 3-hour, and later on six-hourly in the 'with' ScvO2 group, and by clinical variables in the 'without' ScvO2 group. |
T14 |
840-848 |
Sentence |
denotes |
OUTCOME: |
T15 |
849-896 |
Sentence |
denotes |
Primary outcome was all-cause 28-day mortality. |
T16 |
897-1129 |
Sentence |
denotes |
Secondary outcomes were time to and proportion of patients achieving therapeutic endpoints (at 6 hours and PICU stay), need for organ supports, new organ dysfunction (at 24 hours and PICU stay), and length of PICU and hospital stay. |
T17 |
1130-1138 |
Sentence |
denotes |
RESULTS: |
T18 |
1139-1233 |
Sentence |
denotes |
The study was stopped after interim analysis due to lower mortality in the intervention group. |
T19 |
1234-1409 |
Sentence |
denotes |
There was significantly lower all-cause 28-day mortality in EDGT with ScvO2 than without ScvO2 group [37.3% vs. 57.5%, adjusted hazard ratio 0.57, 95%CI 0.33 to 0.97, P=0.04]. |
T20 |
1410-1520 |
Sentence |
denotes |
Therapeutic endpoints were achieved early in 'with' ScvO2 group [mean (SD) 3.6 (1.6) vs. 4.2 (1.6) h, P=0.03]. |
T21 |
1521-1670 |
Sentence |
denotes |
Organ dysfunction by sequential organ assessment score during PICU stay was lower in 'with' ScvO2 group [median (IQR) 5 (2,11) vs. 8 (3,13); P=0.03]. |
T22 |
1671-1735 |
Sentence |
denotes |
There was no significant difference in other secondary outcomes. |
T23 |
1736-1884 |
Sentence |
denotes |
CONCLUSIONS: EGDT with intermittent ScvO2 monitoring was associated with reduced mortality and improved organ dysfunction in pediatric septic shock. |
T1 |
0-132 |
Sentence |
denotes |
Early Goal-Directed Therapy With and Without Intermittent Superior Vena Cava Oxygen Saturation Monitoring in Pediatric Septic Shock: |
T2 |
133-163 |
Sentence |
denotes |
A Randomized Controlled Trial. |
T3 |
164-174 |
Sentence |
denotes |
OBJECTIVE: |
T4 |
175-337 |
Sentence |
denotes |
To compare early goal-directed therapy (EGDT) 'with' and 'without' intermittent superior vena cava oxygen saturation (ScvO2) monitoring in pediatric septic shock. |
T5 |
338-345 |
Sentence |
denotes |
DESIGN: |
T6 |
346-385 |
Sentence |
denotes |
Open label randomized controlled trial. |
T7 |
386-394 |
Sentence |
denotes |
SETTING: |
T8 |
395-451 |
Sentence |
denotes |
Pediatric intensive care unit in a tertiary care center. |
T9 |
452-465 |
Sentence |
denotes |
PARTICIPANTS: |
T10 |
466-517 |
Sentence |
denotes |
Children aged 1 month to 12 year with septic shock. |
T11 |
518-531 |
Sentence |
denotes |
INTERVENTION: |
T12 |
532-668 |
Sentence |
denotes |
Patients not responding to fluid resuscitation (up to 40 mL/kg) were randomized to EGDT 'with' (n=59) and 'without' (n=61) ScvO2 groups. |
T13 |
669-839 |
Sentence |
denotes |
Resuscitation was guided by ScvO2 monitoring at 1-hour, 3-hour, and later on six-hourly in the 'with' ScvO2 group, and by clinical variables in the 'without' ScvO2 group. |
T14 |
840-848 |
Sentence |
denotes |
OUTCOME: |
T15 |
849-896 |
Sentence |
denotes |
Primary outcome was all-cause 28-day mortality. |
T16 |
897-1129 |
Sentence |
denotes |
Secondary outcomes were time to and proportion of patients achieving therapeutic endpoints (at 6 hours and PICU stay), need for organ supports, new organ dysfunction (at 24 hours and PICU stay), and length of PICU and hospital stay. |
T17 |
1130-1138 |
Sentence |
denotes |
RESULTS: |
T18 |
1139-1233 |
Sentence |
denotes |
The study was stopped after interim analysis due to lower mortality in the intervention group. |
T19 |
1234-1409 |
Sentence |
denotes |
There was significantly lower all-cause 28-day mortality in EDGT with ScvO2 than without ScvO2 group [37.3% vs. 57.5%, adjusted hazard ratio 0.57, 95%CI 0.33 to 0.97, P=0.04]. |
T20 |
1410-1520 |
Sentence |
denotes |
Therapeutic endpoints were achieved early in 'with' ScvO2 group [mean (SD) 3.6 (1.6) vs. 4.2 (1.6) h, P=0.03]. |
T21 |
1521-1670 |
Sentence |
denotes |
Organ dysfunction by sequential organ assessment score during PICU stay was lower in 'with' ScvO2 group [median (IQR) 5 (2,11) vs. 8 (3,13); P=0.03]. |
T22 |
1671-1735 |
Sentence |
denotes |
There was no significant difference in other secondary outcomes. |
T23 |
1736-1884 |
Sentence |
denotes |
CONCLUSIONS: EGDT with intermittent ScvO2 monitoring was associated with reduced mortality and improved organ dysfunction in pediatric septic shock. |